This is a working overview of Incretin hormone, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2025-10-16 and is reviewed periodically as new material appears.
The molecule is a synthetic 39-amino-acid peptide whose backbone derives from the sequence of human glucose-dependent insulinotropic polypeptide, with several substitutions that raise metabolic stability and shift receptor preference. A C20 fatty diacid is attached through a short linker to a lysine side chain, a modification that increases binding to serum albumin. The reported monoisotopic mass is approximately 4813 Da. Near neutral pH the peptide carries a net negative charge, and the lipid tail makes the molecule markedly more hydrophobic than the unmodified parent sequence.
Dual agonism at the GIP and GLP-1 receptors underlies the observed pharmacology. Activation of GLP-1 receptors raises glucose-dependent insulin release, lowers glucagon secretion, slows gastric emptying and reduces appetite. GIP receptor activation contributes additional effects on adipose tissue and on energy balance, and the combined action on appetite appears larger than either pathway alone in animal models. Signalling bias and the relative contribution of each receptor arm to weight-related effects remain areas of active investigation.
Structure-activity work shows that fatty acid length, linker chemistry and the position of acylation all influence albumin affinity and receptor potency. Plasma protein binding exceeds 99 percent, which restricts distribution and slows renal clearance. Degradation proceeds largely through general proteolysis and fatty acid oxidation rather than cytochrome P450 metabolism, so exposure to common oxidative drug interactions is limited. Whether these clearance routes vary meaningfully between individuals is not fully established.
Tirzepatide is a synthetic peptide built from thirty-nine amino acids. Its sequence is derived from native glucose-dependent insulinotropic polypeptide, or GIP, with several non-natural residues and a fatty diacid side chain attached through a linker. The molecule behaves as a dual agonist at two incretin receptors, GIP and GLP-1, instead of targeting a single receptor. This dual engagement separates it from earlier single-receptor incretin compounds and underpins most of its reported pharmacological activity.
At the receptor level, the compound binds both GIP and GLP-1 receptors and triggers downstream signalling that raises cyclic AMP in target cells. GLP-1 receptor activation is associated with glucose-dependent insulin release, slower gastric emptying, and reduced appetite signalling. GIP receptor activation contributes effects that are less completely characterised, and how much each receptor adds to the overall clinical response is still an open question. The two pathways appear to interact in a complementary rather than a purely additive way.
An extended fatty diacid moiety promotes binding to serum albumin, which slows renal clearance and extends the circulating half-life to roughly five days. That property supports once-weekly administration and largely explains the dosing interval described in clinical reports. Published data come mainly from large randomised programmes that evaluated glycaemic control and body weight over periods of many months. Long-term outcomes beyond those trial windows, including what happens after treatment stops, remain an active area of investigation.
| Property | Value | Notes |
|---|---|---|
| Molar mass | approximately 4813 Da | calculated from the 39-residue sequence |
| Appearance | white to off-white powder | typical of lyophilised peptide material |
| Solubility class | freely soluble in water | measured value depends on salt form and pH |
| Plasma protein binding | >99 percent | linked to the fatty diacid side chain |
| Class | dual GIP and GLP-1 receptor agonist | receptor activity varies with the assay used |
At the receptor level, tirzepatide activates both the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor. Both belong to the class B family of G protein-coupled receptors and signal largely through cyclic AMP accumulation. The compound binds the two receptors with differing affinity, and the pattern of signaling at each site is described in the literature as biased rather than simply proportional to occupancy. Tissues carrying these receptors include pancreatic islets, adipose tissue, the central nervous system, and the gastrointestinal tract. The relative weight of each receptor population in producing metabolic effects continues to be studied.
Published work supports the view that engaging two incretin receptors produces changes in glucose handling and body weight larger than those seen with single-receptor activation. Why that difference arises is not fully settled. Open questions include how much of the observed weight effect depends on central versus peripheral signaling, and whether the two receptors form interacting complexes. Most reported findings come from controlled trials and animal models, and translation between species is imperfect. Further research is expected to refine these points over time.
Cold-chain handling is standard for formulated product, with dry powder stored frozen and ready-to-use solutions refrigerated. Light exposure is minimized because photodegradation of certain amino acid side chains is possible. Shipping and temperature-excursion studies are used to establish whether short deviations affect quality attributes. Documentation supplied with research material usually includes a certificate of analysis listing purity, identity confirmation, and water or residual solvent content. Users are expected to confirm that material meets the stated specification before use.
Identity and purity of tirzepatide are assessed mainly by reversed-phase high-performance liquid chromatography with ultraviolet detection, often paired with mass spectrometry. Because the molecule carries several modifications, gradient conditions are adjusted to resolve the intact peptide from deamidation and oxidation products. Enzymatic digestion followed by peptide mapping confirms the primary sequence and locates specific modifications. Quantitation in biological matrices typically uses liquid chromatography with tandem mass spectrometry after solid-phase extraction. Immunoassays are used less often, since antibody cross-reactivity with closely related peptides can bias results.
The peptide shares degradation routes common to modified peptides: deamidation of asparagine and glutamine residues, oxidation of methionine, and backbone hydrolysis under extreme pH. Lyophilized material is generally more stable than a solution, and residual water content directly affects the rate of hydrolysis. In liquid form, aggregation and visible particles can appear after agitation or repeated freeze-thaw cycles. Stability studies therefore track monomer content, aggregate content, and potency over months under defined temperature and humidity.
=== Defense in crocodilians === When a crocodilian is concerned about its safety, it will gape to expose the teeth and tongue. If this does not work, the crocodilian gets a little more agitated and typically begins to make hissing sounds. After this, the crocodilian will start to change its posture dramatically to make itself look more intimidating. The body is inflated to increase apparent size. If absolutely necessary, it may decide to attack an enemy.
=== College and service years === Banting finally passed examinations in July 1910. He stated on his application to university that he wished to be a teacher, although he also harbored aspirations of becoming a doctor. He toured the Canadian West for the summer, traveling to Winnipeg and Calgary, before enrolling at the University of Toronto, where he entered the General Arts course at Victoria College. Despite hard work, Banting failed his first year, but decided to become a doctor and returned to repeat the year. He petitioned to join the medical program in February 1912 and was accepted. In September, he dropped out of Victoria College to begin medical school at the University of Toronto. Banting established himself in medical school by working diligently. His roommate, Sam Graham, remembered him for studying late into the night. Besides being a successful rugby player, however, he was otherwise undistinguished. His grades—now without the burden of language courses—saw a marked improvement, averaging approximately a B, an above-average score. Summers were spent returning to work at the farm. At Toronto's Faculty of Medicine, Banting specialised in surgery. At the onset of World War I, Banting, along with most Canadian men, sought to enlist in the army. He attempted to enter the Canadian Expeditionary Force on August 16, 1914, the day after Canada's declaration of war, and then again in October, but was refused twice due to poor vision.
=== OB3b === Methanobactin OB3b is a commonly studied methanobactin. It has a molecular weight of 1154Da when metal free. OB3b is composed of 9 amino acid residues with two oxazolone rings, which take part in binding to copper ions. The oxazalone rings are susceptible to cleavage under low pH conditions, which releases any metal ion bound to the rings. Copper is bound and reduced at a tetradentate binding site composed of 2 oxazolone rings and 2 modified enethiol groups. In particular, the origin and function of these oxazolone rings in methanobactin OB3b has been the subject of research, since these domains appear unique. In 2010, it was suggested that mb OB3b is derived from a small, ribsomally-produced peptide precursor with the sequence of L-C-G-S-C-Y-P-C-S-C-M. Functional mbOB3b is composed of (isobutyl group)-(Oxazolone ring A)-G-S-C-Y-(Oxazolone ring B)-S-M. (Note that some specimens of mBOB3b are found without the C-terminal methionine and appear fully functional.) It has been argued that the chromophoric rings of this particular species of methanobactin enable mbOB3b to bind and reduce other metals. For example, mbOB3b can reduce Ag(I) to Ag(0), Au(III) to Au(0), Cr(VI) to Cr(III), and Hg(II) to Hg(I); it is also able to bind Co(II), Zn (II), Mn(II), Pb(II), and U(IV). Because of this, it is possible that methanobactin may have several medical and environmental applications as a metal chelator and reducing agent. The mechanism of metal reduction is currently undetermined.
Sources: en.wikipedia.org
=== Cancer === Since its initial discovery, Wnt signaling has had an association with cancer. When Wnt1 was discovered, it was first identified as a proto-oncogene in a mouse model for breast cancer. The fact that Wnt1 is a homolog of Wg shows that it is involved in embryonic development, which often calls for rapid cell division and migration. Misregulation of these processes can lead to tumor development via excess cell proliferation. Canonical Wnt pathway activity is involved in the development of benign and malignant breast tumors. The role of Wnt pathway in tumor chemoresistance has been also well documented, as well as its role in the maintenance of a distinct subpopulation of cancer-initiating cells. Its presence is revealed by elevated levels of β-catenin in the nucleus and/or cytoplasm, which can be detected with immunohistochemical staining and Western blotting. Increased β-catenin expression is correlated with poor prognosis in breast cancer patients. This accumulation may be due to factors such as mutations in β-catenin, deficiencies in the β-catenin destruction complex, most frequently by mutations in structurally disordered regions of APC, overexpression of Wnt ligands, loss of inhibitors and/or decreased activity of regulatory pathways (such as the Wnt/calcium pathway). Breast tumors can metastasize due to Wnt involvement in EMT. Research looking at metastasis of basal-like breast cancer to the lungs showed that repression of Wnt/β-catenin signaling can prevent EMT, which can inhibit metastasis.
== Causes == While the exact cause is unclear, it is believed to involve a combination of genetics and an environmental trigger such as exposure to a virus or bacterium, as is the case with many other autoimmune disorders. Around 20 autoantibodies could be involved. It can occur independently of other health problems or as a result of another connective tissue disorder. Sjögren's disease may be associated with other autoimmune diseases, including rheumatoid arthritis (RA), systemic lupus erythematosus (SLE) or systemic sclerosis. The inflammation that results progressively damages the glands. Diagnosis is by biopsy of moisture-producing glands and blood tests for specific antibodies. On biopsy there are typically lymphocytes within the glands.
== History == The Roman anatomist Galen commented on Hippocrates' work, classifying teeth as bones, noting their distinct characteristics compared to other bones. He was the first to discover nerves in teeth and identified seven cranial nerves in his research.
== Awards == 2000 – National Bleeding Disorders Foundation, Researcher of the Year award 2009 – Foundation Fighting Blindness, Board of Directors Award 2010 – American Society of Gene and Cell Therapy, Outstanding Achievement Award 2014 – Human Gene Therapy, Pioneer Award 2018 – Sanford Health's $1 million Lorraine Cross Award for innovation in medicine and science, shared with Jean Bennett 2022 – American Society of Gene and Cell Therapy, Jerry Mendell Award for Translational Science 2022 – Children's Hospital of Philadelphia, Gold Medal for transformative impact on children's health through gene therapy 2026 – Breakthrough Prize in Life Sciences
Sources: en.wikipedia.org
March 30: Law modifying the law of November 2, 1892, on labor by children, underage girls, and women in industrial establishments: the maximum daily working hours for minors under 18 and for women is reduced to 10 hours. December 1: Law allowing women with a university degree (license) to take the oath as lawyers and practice the profession. December 29: Law defining working conditions for women employed in shops, stores, and related premises. March 31, 1902: Decree creating Agricultural Chambers in Algeria: in elections to these chambers, French women who retain their civil rights (i.e., single, divorced or legally separated, or widowed) may vote (but are not eligible to be elected). 1903
In response to Estadão, the Ministry of Communications released a statement with its position regarding the trip. The statement affirms that the minister had official commitments during the trip to the state of São Paulo:The minister fulfilled an official agenda on 26 and 27 January, participating in meetings with the operator Claro, where the company's investment plan in the country was presented; [he also participated in] a technical meeting with the team of the regional office of the affiliated Telebrás; a meeting with the regional manager of the affiliated agency Anatel; and [participated in] a visit and meeting with the BYD group in SP.In an exclusive interview with journalist Reinaldo Azevedo on BandNews FM, Lula declared:I tried this week to talk with Juscelino; minister Juscelino is traveling, he is abroad on ministry business discussing at the telecommunications meeting. I have already asked minister Rui Costa to summon him for Monday so that we can have a conversation because he has the right to prove his innocence, but if he cannot prove his innocence he cannot remain in the government. I guarantee everyone the presumption of innocence.Pressured by allies and opponents regarding the permanence or dismissal of the minister, the president met with Juscelino on 6 March to demand explanations from him regarding the accusations. After the meeting, Lula decided to keep the minister. On his official Twitter profile, Juscelino published:I have just left the Palácio do Planalto, where I had a very positive meeting with president Lula.
== International broadcast == The series will be broadcast by Star Chinese Channel outside of China and Mediacorp Channel 8 in Singapore every Saturday, 10:30pm to 12:30am the next day, broadcasting two episodes in a day. It first aired in Thailand on Channel 3 in 2021 daily at 2:50 am starting Friday 27 August, following Eternal Love (rerun) finished.
VIP is highly localised in lungs (70%) and binds with alveolar type II (AT II) cells via VPAC1. The biological (vasodilator) activity of vasoactive intestinal peptide (VIP) was discovered in the lungs before the peptide was isolated and chemical identity characterized from intestine. VIP levels are also considerably high in the brain and the gut. It is localized in key sites in the lung, has potent activities on its major functions, and appears to play an important role in pulmonary physiology and disease. The principal localization of VIP-containing neurons in the tracheobronchial tree is in the smooth muscle layer, around submucosal mucous glands and in the walls of pulmonary and bronchial arteries. Immunoreactive VIP is also present in neuronal cell bodies forming microglia that provide a source of intrinsic innervation of pulmonary structures.
Naturally occurring rhenium (75Re) is 37.4% 185Re, which is stable (although it is predicted to decay), and 62.6% 187Re, which is unstable but has a very long half-life (4.16×1010 years). Among elements with a known stable isotope, only indium and tellurium similarly occur with a stable isotope in lower abundance than the long-lived radioactive isotope. There are 36 other unstable isotopes recognized, the longest-lived of which are 183Re with a half-life of 70 days, 184Re with a half-life of 35.4 days, 186Re with a half-life of 3.7185 days, 182Re with a half-life of 64.2 hours, and 189Re with a half-life of 24.3 hours. There are also numerous isomers, the longest-lived of which are 186mRe with a half-life of 200,000 years and 184mRe with a half-life of 177.25 days. All others have half-lives less than a day.
Sources: en.wikipedia.org
It is a synthetic peptide of 39 amino acids bearing a lipid side chain. Its size and architecture place it outside the small-molecule class, and laboratories generally handle it with the precautions used for biologic-like molecules.
The fatty diacid side chain promotes strong binding to serum albumin, which slows clearance and yields a half-life of roughly five days. That profile supports once-weekly administration in clinical use.
In vitro assays detect activity at both the GIP and GLP-1 receptors, but the activity ratio depends on the assay system and the signalling pathway measured. The relative contribution of each receptor to clinical effects is still being characterised.
It acts as a dual agonist at the GIP receptor and the GLP-1 receptor. This broader targeting profile distinguishes it from selective GLP-1 agonists, which engage only one receptor.